🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effectiveness of a Culturally Adapted Online Education Program (iSupport-Korea) for Family Caregivers of People With Dementia

RecruitingNAAges 19 Years - anyAllChungnam National University
NCT07609316 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This randomized controlled trial evaluates the effectiveness of iSupport-Korea, a culturally adapted online education program for family caregivers of people with dementia. A total of 160 caregivers will be randomly assigned to either the intervention or control group and followed for 4 months. The investigators hypothesize that the intervention group will show greater improvements in care-related quality of life, caregiver self-efficacy, and family decision-making self-efficacy.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adults aged 19 years or older * Family caregivers currently providing care for a person diagnosed with dementia * Informal caregivers such as spouse, children, or relatives * Living with the person with dementia or providing regular care even if not cohabiting * Able to read and understand Korean and communicate in Korean * Able to use digital devices (e.g., smartphone, tablet, or computer) to access an online program * Willing to provide informed consent and participate in the study Exclusion Criteria: * Not currently providing direct care to a person with dementia * Participating in another dementia caregiver intervention or similar study * Having severe cognitive impairment, psychiatric illness, or communication difficulties that limit participation * Having severe visual or hearing impairment that interferes with program use * Unable to complete follow-up assessments during the study period
💊

What it tests

  • iSupport-Korea
  • Dementia information website
📍

Where

1 site
College of Nursing, Chungnam National University
Daejeon, South Korea
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy